1.Abdominal wall plastic surgery combined with endometriosis nodule resection: 2 case reports
Yuanqing CAO ; Hongyu LIU ; Jianfa RAO ; Xiangyu ZI
Chinese Journal of Plastic Surgery 2025;41(9):922-925
This article reports two patients who developed abdominal wall endometriosis(AWE) after cesarean section and had the need for abdominal wall plastic surgery. The problems of AWE treatment and abdominal shape improvement were simultaneously solved through a single combined surgery (abdominal wall plastic surgery + resection of endometriotic nodules), and the follow-up at half a year after the operation presented good appearance.
2.Abdominal wall plastic surgery combined with endometriosis nodule resection: 2 case reports
Yuanqing CAO ; Hongyu LIU ; Jianfa RAO ; Xiangyu ZI
Chinese Journal of Plastic Surgery 2025;41(9):922-925
This article reports two patients who developed abdominal wall endometriosis(AWE) after cesarean section and had the need for abdominal wall plastic surgery. The problems of AWE treatment and abdominal shape improvement were simultaneously solved through a single combined surgery (abdominal wall plastic surgery + resection of endometriotic nodules), and the follow-up at half a year after the operation presented good appearance.
3.Hysteroscopic Treatment for 31 Cases of Angioleiomyomas in the Uterine Cavity and Cervical Canal
Chinese Journal of Minimally Invasive Surgery 2024;24(12):791-794
Objective To explore the therapeutic effect of hysteroscopic treatment for angioleiomyomas in the uterine cavity and cervical canal.Methods A retrospective analysis was conducted on clinical data of 31 cases of hysteroscopic treatment for angioleiomyomas in the uterine cavity and cervical canal from March 2012 to October 2023.The manifestations included abnormal uterine bleeding in 23 cases,abnormal intrauterine echoes or thickened endometrium indicated by ultrasound in 7 cases,and self-reported protrusion of a mass from the vulva in 1 case.Results Hysteroscopic examination revealed that the lesions were located in the uterine cavity in 26 cases and in the cervical canal in 5 cases,with single lesions in 27 cases and multiple lesions in 4 cases.Hysteroscopic diagnosis identified 22 cases of fibroids,4 cases of polyps,and 5 cases of undetermined types.All the lesions were completely excised under hysteroscopy,and the postoperative pathological diagnosis was angioleiomyomas.Postoperative follow-ups ranged from 3 to 142 months,with a median of 69 months.Ultrasound indicated no recurrence.Conclusion For angioleiomyoma located in the uterine cavity and cervical canal,complete excision of the lesion through hysteroscopy is an effective treatment method.
4.Effect of BLV-miRNAs on milk lactoperoxidase
Yandi WANG ; Guichi LIU ; Yuejie YANG ; Jianfa WANG ; Shuai LIAN ; Rui WU
Chinese Journal of Veterinary Science 2024;44(6):1274-1279
This study aims to investigate the effect of bovine leukemia virus encoded microRNAs(BLV-miRNAs)on lactoperoxidase(LPO)in bovine mammary epithelial cells(BMECs).Firstly,the LPO content in the milk of BLV-positive cows,categorized by different viral loads,was quanti-fied by enzyme-linked immunosorbent assay(ELISA).Subsequently,BMECs were cultured in vitro and infected with(1 MOI)full-length BLV and BLV lacking miRNAs(BLV-ΔmiRNAs).Va-rious analytical techniques,including fluorescent quantitative PCR and ELISA,were used to assess LPO expression levels in different BMEC cohorts.Ten BLV-miRNAs were computationally predic-ted to target LPO using software tools such as StarMir.Based on these predictions,transfections of BLV-miRNAs were carried out and preliminary verification of their effects on target genes were performed.The results showed that compared to that of BLV-negative counterparts,the LPO levels in the milk of BLV-positive cows,stratified by high and low viral load,decreased by 8.73%and 9.68%,respectively.Invitro experiments further corroborated these trends,revealing a significant increase(P<0.05)in LPO expression within BMECs following the deletion of BLV-miRNAs compared to the group infected with full-length BLV-infected group.Computational target site pre-dictions implicated BLV-miR-B1-5p,B3-3p,and B4-5p in the collective regulation of the LPO gene.Transfection of BLV-miR-B1-5p into BMECs resulted in a significant downregulation of LPO gene expression(P<0.05),with the effect intensifying proportionally with the transfection dose.Simi-larly,the transfection of BLV-miR-B4-3p into BMECs significantly reduced LPO gene expression(P<0.05)without showing a dose-dependent behavior.In conclusion,this research indicates that BLV-miRNAs can suppress LPO expression in BMECs.
5.Hysteroscopic Treatment for 31 Cases of Angioleiomyomas in the Uterine Cavity and Cervical Canal
Chinese Journal of Minimally Invasive Surgery 2024;24(12):791-794
Objective To explore the therapeutic effect of hysteroscopic treatment for angioleiomyomas in the uterine cavity and cervical canal.Methods A retrospective analysis was conducted on clinical data of 31 cases of hysteroscopic treatment for angioleiomyomas in the uterine cavity and cervical canal from March 2012 to October 2023.The manifestations included abnormal uterine bleeding in 23 cases,abnormal intrauterine echoes or thickened endometrium indicated by ultrasound in 7 cases,and self-reported protrusion of a mass from the vulva in 1 case.Results Hysteroscopic examination revealed that the lesions were located in the uterine cavity in 26 cases and in the cervical canal in 5 cases,with single lesions in 27 cases and multiple lesions in 4 cases.Hysteroscopic diagnosis identified 22 cases of fibroids,4 cases of polyps,and 5 cases of undetermined types.All the lesions were completely excised under hysteroscopy,and the postoperative pathological diagnosis was angioleiomyomas.Postoperative follow-ups ranged from 3 to 142 months,with a median of 69 months.Ultrasound indicated no recurrence.Conclusion For angioleiomyoma located in the uterine cavity and cervical canal,complete excision of the lesion through hysteroscopy is an effective treatment method.
6.Study of risk factors associated with prognosis in patients with aortic acute cerebral infarction
Na LIU ; Jianfa REN ; Weiying DI ; Yanan CHEN ; Yun CAI
Clinical Medicine of China 2022;38(6):521-526
Objective:To explore the risk factors associated with a three-month prognosis in patients with aortic acute cerebral infarction.Methods:A prospective study was conducted on 191 patients with aorthropathic acute cerebral infarction included in the Department of Neurology from June 2018 to December 2019, and the patients were divided into good prognosis group (153 cases) and poor prognosis group (38 cases) according to the MRS score of the patient's 3-month prognosis, and the general data, past medical history and blood pressure variability evaluation index (BPV) between the two groups were correlated analysis. The t-test was used to compare the measurement data with normal distribution, the χ 2 test was used to compare the counting data, and the Logistic regression analysis was used to analyze the risk factors. Results:The proportion of patients with diabetes history in the poor prognosis group (20.3% (31/153)), admission NIHSS score ((3.03±2.01) points), standard deviation (SD) ((12.06±4.46) mmHg) and coefficient of variation (CV) ((8.61±3.08)%) of systolic blood pressure at 24 h were lower than those in the good prognosis group (47.4% (18/38), (5.61±3.84) points, (14.75±3.46) mmHg, (10.41±2.18)%), the differences were statistically significant (the statistical values were χ 2=11.73, t=4.01, t=3.46, t=3.38; P values were 0.001, <0.001, 0.001, and 0.001, respectively). Because 24 h systolic blood pressure SD and 24 h systolic blood pressure CV had obvious collinearity, they were respectively included in the Logistic regression model. Taking diabetes history, NIHSS score and 24 h systolic blood pressure SD into the variables, the multivariate Logistic regression results of adverse prognostic risk factors in patients with acute cerebral infarction showed that the history of diabetes mellitus ( OR=3.649, 95% CI: 1.545-8.648, P=0.003), NIHSS score ( OR=1.472, 95% CI: 1.247-1.725, P<0.001) and 24 h systolic blood pressure SD ( OR=1.201, 95% CI: 1.085-1.336, P<0.001). Taking diabetes history, NIHSS score and 24 h systolic blood pressure CV into consideration, multivariate Logistic regression results of adverse prognostic risk factors in patients with acute cerebral infarction showed that the history of diabetes mellitus ( OR=4.695, 95% CI: 1.873-11.766, P=0.001), admission NIHSS score ( OR=1.922, 95% CI: 1.513-2.441, P<0.001) and 24 h systolic blood pressure CV ( OR=1.220, 95% CI: 1.045-1.425, P=0.012). All are independent risk factors influencing the prognosis of patients. Conclusion:The effect of 24 h systolic blood pressure SD and 24 h systolic blood pressure CV on patient prognosis was more valuable in clinical prediction, and the prognosis value of controlling blood glucose levels in patients with diabetes was higher in patients with cerebral infarction.
7.Study of correlation between biochemical markers of bone metabolism and postmenopausal osteoporotic vertebral fractures
Shaochuan HUO ; Lujue DONG ; Hongyu TANG ; Yong LIU ; Hai GUO ; Jianfa CHEN ; Zhangrong DENG ; Delong CHEN ; Haibin WANG
Chongqing Medicine 2017;46(1):48-50
Objective To study correlation between biochemical markers of bone metabolism and postmenopausal osteoporot-ic vertebral fractures.Methods The clinical data of 100 cases with postmenopausal osteoporotic were study retrospectively.Fifty patients were postmenopausal osteoporotic,the rests were postmenopausal osteoporotic vertebral fractures.Lumbar spine,hip BMD,serum P1NP,β-CTX,N-MID,25-(OH)VitD and Ca2 + were recorded.Results There was a significant difference among ser-um P1NP,β-CTX and 25-(OH)VitD(P <0.05 ).There was positive correlation between postmenopausal osteoporotic vertebral fracture with serum P1NP (P <0.05),and negative correlation with serum 25-(OH)VitD (P <0.05),but had no correlation with serumβ-CTX (P >0.05).Conclusion Serum P1NP and 25-(OH)VitD could predict risk of postmenopausal osteoporotic vertebral fractures.Biochemical markers of bone metabolism combined with BMD could reduce postmenopausal osteoporosis fractures.
8.Risk factors for heterotopic ossification following total hip arthroplasty in patients with ankylosing spondylitis
Yong LIU ; Shaochuan HUO ; Chi ZHOU ; Hongyu TANG ; Delong CHEN ; Jianfa CHEN ; Hai GUO ; Zhangrong DENG ; Haibin WANG
Chinese Journal of Tissue Engineering Research 2017;21(11):1641-1646
BACKGROUND: Heterotopic ossification (HO) is common following primary total hip arthroplasty (THA) in patients with ankylosing spondylitis (AS), which may cause certain influence on functional recovery.OBJECTIVE: To explore the risk factors for HO after primary THA in AS patients.METHODS: The clinical and radiological data from 87 patients (132 hips) with AS undergoing primary THA between June 2011 and December 2015 were retrospectively analyzed, and followed up for more than 6 months. The radiological information included preoperative and postoperative hip anteroposterior and lateral radiographs. The presence of HO surrounding the prosthesis was evaluated on the radiographs at the last follow-up and graded according to the Brooker classification. Risk factors for HO were divided into invariable factors (age, sex, course and with or without ankylosed hip) and variable factors (preoperative C-reactive protein level, preoperative erythrocyte sedimentation rate, intraoperative blood loss, operation time, prosthesis types and anesthesia methods) to determine the pertinent risk factors.RESULTS AND CONCLUSION: (1) Totally 43 hips (32.6%) were found to have developed into HO. (2) Invariable risk factors including male (P=0.029), preoperative ankylosed hip (P < 0.001), and course (P=0.029) increased the prevalence of HO. Among the variable risk factors, prolonged operation time (P=0.031) and general anesthesia (P=0.003)were associated with the increased occurrence of HO. Age, preoperative C-reactive protein level and erythrocyte sedimentation rate, intraoperative blood loss, and prosthesis types had no obvious correlation with HO. (3) These results suggest that to prevent the formation of HO following THA in AS, efforts to reduce the operation time and avoid general anesthesia should be considered.
9.Expression of jumonji domain-containing histone demethylase 2 and estrogen-related receptor alpha in postmenopausal osteoporosis
Hongyu TANG ; Lujue DONG ; Shaochuan HUO ; Cheng GUO ; Chi ZHOU ; Jianfa CHEN ; Yong LIU ; Haibin WANG
Chinese Journal of Tissue Engineering Research 2016;(2):167-172
BACKGROUND:Jumonji domain-containing histone demethylase (JMJD) can promote osteoblast differentiation, and estrogen-related receptor alpha (ERRα) can promote osteoblast differentiation and increase bone formation. However, little is reported on the association between postmenopausal osteoporosis andJMJD and ERRα. OBJECTIVE: To study the changes in the JMJD2 family expression in patients with postmenopausal osteoporosis. METHODS: Postmenopausal patients with osteoarthritis of the hip scheduled for total hip arthroplasty, aged 50-70 years, were enroled, including 10 postmenopausal osteoporosis patients (experimental group) and 10 patients with no postmenopausal osteoporosis (control group). During the arthroplasty, the cancelous bone specimens from the femoral head were colected. Then, immunohistochemistry and western blot assay were used to detect expression of histone demethylase (JMJD2A, JMJD2B), histone methylation (H3K9me3, H3K36me3) and ERRα. RESULTS AND CONCLUSION:In the experimental group, the expressions of JMJD2A, JMJD2B and ERRαwere from weakly positive to positive; these expressions were significantly lower in the experimental group than the control group (P < 0.05). The expressions of H3K9me3 and H3K36me3 were significantly higher in the experimental group than the control group (P < 0.05). These findings indicate that the expression of JMJD2A and JMJD2B is consistent with the expression of ERRα in the patients with postmenopausal osteoporosis, and JMJD is likely to serve as an antagonistic enzyme of osteoporosis.
10.Relationship between thyroid function and cardiovascular diseases
Mei LIU ; Bingfeng ZHOU ; Youwei SHI ; Shaodong XU ; Ying MENG ; Jianfa ZHENG ; Qinghe XU ; Minyu LIU ; Ying GAO ; Fei GAO ; Wei LIU
Chinese Journal of cardiovascular Rehabilitation Medicine 2015;24(3):267-270
Objective:To explore the relationship between thyroid function and cardiovascular diseases .Methods:A total of 980 patients undergoing thyroid function examination during hospitalization were selected . According to their thyroid function ,they were divided into normal thyroid function group (normal group ,n= 930) , hyperthy-roidism group (n=18) ,and hypothyroidism group (n=32) .Clinical data were analyzed ,blood lipids and coagula-tion function indexes were examined and compared among three groups . Results:Compared with normal group ,the incidence rate of atrial fibrillation significantly rose ,incidence rate of hypertension ,cardiac insufficiency signifi-cantly reduced;levels of TC、TG、 LDL-C、 HDL-C significantly reduced ,activated partial thromboplastin time significantly extended in hyperthyroidism group , P<0.01 all;incidence rate of coronary heart disease significantly rose ,levels of TG、HDL-C significantly rose ,levels of TC 、LDL-C significantly reduced in hypothyroidism group , P<0.01 all;Compared with hyperthyroidism group ,the incidence rate of hypertension ,coronary heart disease sig-nificantly rose ,atrial fibrillation significantly reduced ,P<0.05 or <0.01 ;levels of TG、LDL-C、HDL-C signifi-cantly rose ,TC level significantly reduced in hypothyroidism group , P<0. 01 all .Conclusion:Thyroid function is closely related to cardiovascular diseases .so it′s suggested that thyroid function detection should be regarded as a routine examination in patients with cardiovascular diseases and a follow-up index for those with thyroid dysfunc-tion .

Result Analysis
Print
Save
E-mail